Analysis of the Listing and Regulatory Policy for Traditional Chinese Medicine Products in Brazil and the Enlightenment for China

Yuan Bo, Sun Fuyun, Lu Zhong, Mo Jieli, Yao Lixin, Wu Guiping

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (5) : 583-587.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (5) : 583-587. DOI: 10.16153/j.1002-7777.2023.05.012
Foreign Pharmacy

Analysis of the Listing and Regulatory Policy for Traditional Chinese Medicine Products in Brazil and the Enlightenment for China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(5): 583-587 https://doi.org/10.16153/j.1002-7777.2023.05.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉